Nothing Special   »   [go: up one dir, main page]

SI1931704T1 - Priprava in čiščenje IL-29 - Google Patents

Priprava in čiščenje IL-29

Info

Publication number
SI1931704T1
SI1931704T1 SI200630952T SI200630952T SI1931704T1 SI 1931704 T1 SI1931704 T1 SI 1931704T1 SI 200630952 T SI200630952 T SI 200630952T SI 200630952 T SI200630952 T SI 200630952T SI 1931704 T1 SI1931704 T1 SI 1931704T1
Authority
SI
Slovenia
Prior art keywords
methods
production
purification
coli
vectors
Prior art date
Application number
SI200630952T
Other languages
English (en)
Inventor
Bruce L Zamost
Geoffrey F Lee
Robert M Dedinsky
Original Assignee
Zymogenetics L L C
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics L L C, Bristol Myers Squibb Co filed Critical Zymogenetics L L C
Publication of SI1931704T1 publication Critical patent/SI1931704T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200630952T 2005-10-04 2006-10-04 Priprava in čiščenje IL-29 SI1931704T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72354405P 2005-10-04 2005-10-04
PCT/US2006/039139 WO2007041713A1 (en) 2005-10-04 2006-10-04 Production and purification of il-29
EP06816409A EP1931704B1 (en) 2005-10-04 2006-10-04 Production and purification of il-29

Publications (1)

Publication Number Publication Date
SI1931704T1 true SI1931704T1 (sl) 2011-04-29

Family

ID=37603659

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630952T SI1931704T1 (sl) 2005-10-04 2006-10-04 Priprava in čiščenje IL-29

Country Status (15)

Country Link
US (6) US20080096252A1 (sl)
EP (1) EP1931704B1 (sl)
JP (3) JP5364375B2 (sl)
AT (1) ATE491722T1 (sl)
AU (1) AU2006299339B2 (sl)
CA (1) CA2625208A1 (sl)
CY (1) CY1112323T1 (sl)
DE (1) DE602006018969D1 (sl)
DK (1) DK1931704T3 (sl)
ES (1) ES2357152T3 (sl)
IL (2) IL189994A (sl)
PL (1) PL1931704T3 (sl)
PT (1) PT1931704E (sl)
SI (1) SI1931704T1 (sl)
WO (1) WO2007041713A1 (sl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2295450B1 (en) 2000-09-29 2015-01-28 Merck Sharp & Dohme Corp. Pegylated interleukin-10
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
EP1927600A1 (en) * 2003-08-07 2008-06-04 Zymogenetics, Inc. Homogeneous preparations of IL-28 and IL-29
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
US20070053933A1 (en) * 2005-07-20 2007-03-08 Sheppard Paul O IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
DK1931704T3 (da) 2005-10-04 2011-03-14 Zymogenetics L L C Frembringelse og rensning af IL-29
CL2008002054A1 (es) * 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
CN101918440B (zh) * 2007-09-20 2015-04-22 联邦科学技术研究组织 禽类细胞因子及编码其的遗传序列的应用
US20110034672A1 (en) * 2008-01-18 2011-02-10 Roberto Falkenstein Purification of not-glycosylated polypeptides
AU2009255994B2 (en) * 2008-06-05 2014-07-17 Bristol-Myers Squibb Company Use of pegylated Type III Interferons for the treatment of hepatitis C
WO2010059232A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
PL2379115T3 (pl) 2008-12-17 2018-03-30 Merck Sharp & Dohme Corp. Wytwarzanie i zastosowania mono- i di-peg il-10
WO2010118409A1 (en) * 2009-04-10 2010-10-14 Ls9, Inc. Production of commercial biodiesel from genetically modified microorganisms
WO2011098644A2 (es) 2010-02-09 2011-08-18 Proyecto De Biomedicina Cima, S.L. Composiciones para el tratamiento de enfermedades infecciosas y tumorales
JP5768341B2 (ja) * 2010-08-04 2015-08-26 東ソー株式会社 Ｆｃ結合性タンパク質の製造方法
CN102584979B (zh) * 2011-01-18 2015-10-14 北京凯因科技股份有限公司 PEG化干扰素λ
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
CN103228792A (zh) * 2011-08-25 2013-07-31 纳诺亘医药生物科技公司 PEG-干扰素λ1结合物
US8454947B1 (en) 2012-03-01 2013-06-04 Nanogen Pharmaceutical Biotechnology PEG-interferon lambda 1 conjugates
RU2549710C2 (ru) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
CN104045704B (zh) * 2013-03-11 2016-08-10 中国医学科学院基础医学研究所 PEG化重组人IFN-λ1、其制备方法和用途
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
EP3010527B1 (en) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Method for assessing protein identity and stability
WO2015008302A1 (en) * 2013-07-19 2015-01-22 Biogenomics Limited Apparatus for refolding of recombinant proteins
AU2014311432A1 (en) 2013-08-30 2016-03-03 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
AU2014346537A1 (en) 2013-11-11 2016-05-19 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN104968673B (zh) 2014-01-08 2018-11-02 德益阳光生物技术（北京）有限责任公司 融合多肽及使用方法
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
CN106573072A (zh) 2014-06-02 2017-04-19 阿尔莫生物科技股份有限公司 降低血清胆固醇的方法
CN107001438A (zh) 2014-10-14 2017-08-01 阿尔莫生物科技股份有限公司 白细胞介素‑15组合物及其用途
CA2963995A1 (en) 2014-10-22 2016-04-28 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
AU2015369808A1 (en) * 2014-12-23 2017-06-29 Armo Biosciences, Inc. Methods of improving yield in recombinant protein production
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
JP2018517673A (ja) 2015-04-21 2018-07-05 アイガー・バイオファーマシューティカルズ・インコーポレイテッドＥｉｇｅｒ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ロナファルニブおよびリトナビルを含む医薬組成物
JP7121496B2 (ja) 2015-05-28 2022-08-18 アルモ・バイオサイエンシーズ・インコーポレイテッド 癌治療で使用するためのペグ化インターロイキン－１０
KR20180038553A (ko) 2015-08-25 2018-04-16 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
DK3416675T3 (da) 2016-02-19 2021-06-14 Eiger Biopharmaceuticals Inc Behandling af hepatitis-delta-virusinfektion med interferon lambda
MX2019004717A (es) 2016-11-07 2019-08-05 Seattle Genetics Inc Distribucion de casquetes de cisteina modificados.
KR102700388B1 (ko) 2019-02-24 2024-08-30 온코시미스 바이오테크 프라이빗 리미티드 박테리아에 의한 재조합 glp-1 펩타이드의 연속 생성 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795077A (en) * 1988-05-23 1989-01-03 Motorola Inc. Bonding method and apparatus
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
JP2002531089A (ja) * 1998-11-30 2002-09-24 イーライ・リリー・アンド・カンパニー 赤血球産生性化合物
CZ299516B6 (cs) * 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
ES2286128T3 (es) * 2000-06-30 2007-12-01 Zymogenetics, Inc. Proteina zcyto21 tipo interferon.
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
US7135170B2 (en) * 2002-10-23 2006-11-14 Zymogenetics, Inc. Methods for treating viral infection using IL-28 and IL-29
ES2334127T3 (es) * 2002-12-13 2010-03-05 Zymogenetics, Inc. Produccion de il-21 en huespedes procariotas.
EP1927600A1 (en) * 2003-08-07 2008-06-04 Zymogenetics, Inc. Homogeneous preparations of IL-28 and IL-29
US20050244423A1 (en) * 2004-04-02 2005-11-03 Klucher Kevin M Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
AU2005266892B2 (en) * 2004-07-29 2011-03-03 Bristol-Myers Squibb Company Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
CN1305902C (zh) * 2004-11-25 2007-03-21 汕头大学医学院 一种人白细胞介素29的生产方法及重组il－29工程菌
ATE521633T1 (de) * 2004-12-10 2011-09-15 Zymogenetics Inc Fgf18 produktion in prokaryotischen zellen
JP4987001B2 (ja) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー 癌および自己免疫障害を処置するためのｉｌ２８およびｉｌ２９の短縮型システイン変異体の使用法
DK1931704T3 (da) 2005-10-04 2011-03-14 Zymogenetics L L C Frembringelse og rensning af IL-29

Also Published As

Publication number Publication date
EP1931704A1 (en) 2008-06-18
US8211670B2 (en) 2012-07-03
AU2006299339A1 (en) 2007-04-12
PL1931704T3 (pl) 2011-06-30
US20130143270A1 (en) 2013-06-06
JP2013099337A (ja) 2013-05-23
US7968315B2 (en) 2011-06-28
AU2006299339B2 (en) 2012-03-15
JP5364375B2 (ja) 2013-12-11
US20100222552A1 (en) 2010-09-02
ES2357152T3 (es) 2011-04-19
US20120015403A1 (en) 2012-01-19
EP1931704B1 (en) 2010-12-15
CA2625208A1 (en) 2007-04-12
JP2012235789A (ja) 2012-12-06
JP2009510173A (ja) 2009-03-12
US7759092B2 (en) 2010-07-20
IL227691A0 (en) 2013-09-30
PT1931704E (pt) 2011-03-28
IL189994A0 (en) 2008-08-07
CY1112323T1 (el) 2015-12-09
US8759027B2 (en) 2014-06-24
IL189994A (en) 2013-08-29
WO2007041713A1 (en) 2007-04-12
US20100003722A1 (en) 2010-01-07
US20080096252A1 (en) 2008-04-24
ATE491722T1 (de) 2011-01-15
DE602006018969D1 (de) 2011-01-27
DK1931704T3 (da) 2011-03-14
US20120271037A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
IL227691A0 (en) Creation and purification of 29 – il
ATE492633T1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
SI1948789T1 (sl) Postopek za pridobivanje permanentnih humanih celičnih linij
MY172991A (en) Interleukin-2 muteins for the expansion of t-regulatory cells
MX2012006096A (es) Polipeptidos que tienen actividad glucoamilasa y polinucleotidos que codifican para los mismos.
MX2009012846A (es) Polipeptidos que tienen actividad celulosica mejorada y polinucleotidos que los codifican.
ATE515568T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
TW200740841A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
MX2012015142A (es) Polipeptidos que tiene actividad beta-glucosidasa y usos del mismo.
IN2012DN02120A (sl)
EP3805348A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
AU2010325787A8 (en) Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
UA95083C2 (ru) Азеотропная или близкая к азеотропной композиции, которые содержат 1,1,1,2,3-пентафторопропен и фтороводород, способы отделения и получения 1,1,1,2,3-пентафторопропена
SI1941027T1 (sl) Postopki in sredstva za proliferacijo zarodnih celic in kasnejšo generacijo in ekspanzijo progenitorskih celic, kot tudi izdelava efektor celic kot kliničnih zdravil
MX2012003473A (es) Polipeptidos que tienen actividad celulitica mejorada y polinucleotidos que codifican para los mismos.
MX2011010494A (es) Polipeptidos que tienen actividad de celulasa.
MX2012006095A (es) Polipeptidos que tienen actividad glucoamilasa y polinucleotidos que codifican para los mismos.
ATE447013T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
IN2015DN01788A (sl)
ATE521633T1 (de) Fgf18 produktion in prokaryotischen zellen
TW200734350A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
MX342444B (es) Metodo para purificar eritropoyetina conjugada con polietilenglicol (peg).
AU2003223124A1 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
WO2009058451A3 (en) Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells
TW200700076A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same